Jaguar Health Converts Series R Preferred Shares Into Common Stock

What happened

Jaguar Health completed the conversion of its Series R preferred shares into common shares on November 2, 2026, at a rate of five common shares for each preferred share. Afterward, it had 13,345,986 common shares issued and outstanding; eligible warrant holders may receive up to 69,823 additional shares if they exercise their warrants.

Confirmed

Global impact / market context

The conversion changes the mix of Jaguar Health’s shares and establishes a larger stated common-share count, while warrant exercises could add shares beyond that total. More shares can spread any future company value across more ownership units, but the article gives no information about proceeds, operating performance, or investor response.

Analyst inference

The article reports a completed share conversion, not a new financing or a change in business results. It does not state whether the conversion brought cash into the company. Any additional shares depend on eligible warrant holders choosing to exercise, so the stated potential issuance is not certain.

Analyst inference

What to watch

1. Check later disclosures for whether eligible warrant holders exercised warrants and how many common shares were issued, since the article describes up to 69,823 as conditional. Analyst inference
2. Look for updated filings that reconcile the 13,345,986 common shares outstanding with any shares subsequently issued through warrant exercises. Analyst inference
3. Review future company updates for operating results or cash raised; the article reports the conversion but does not state its effect on finances or business performance. Analyst inference

Evidence

• Original source link unavailable